Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
25 Nov 2014 Withdrawal of the Marketing Authorisation Application for Balugrastim Bioethics, legal and economic issues - Palliative and supportive care
24 Nov 2014 NICE Is Updating Its Guideline on Suspected Cancer to Help GPs Spot the Early Signs and Symptoms of Cancer Bioethics, legal and economic issues
24 Nov 2014 Immuno-Oncology 2014 Press Release: High-Dose Interleukin-2 Effective in mRCC Pre-Treated With VEGF-Targeted Therapies Genitourinary cancers - Cancer Immunology and Immunotherapy
21 Nov 2014 Immuno-Oncology 2014 Press Release: Immune Checkpoint Inhibitors May Work in Brain Cancer Central nervous system malignancies - Cancer Immunology and Immunotherapy
21 Nov 2014 Immuno-Oncology 2014 Press Release: Possibilities for Personalised Vaccines Revealed at ESMO Symposium Personalised medicine - Cancer Immunology and Immunotherapy
21 Nov 2014 A Mutation Signature for Clinical Response to Immune Checkpoint Inhibitors Translational research - Melanoma - Cancer Immunology and Immunotherapy
20 Nov 2014 Immuno-Oncology 2014 Press Release: Immunotherapy Set to Revolutionise Cancer Treatment Cancer Immunology and Immunotherapy
20 Nov 2014 Patients with Advanced Papillary RCC Respond Well to a Combination of Bevacizumab and Erlotinib Genitourinary cancers - Anticancer agents & Biologic therapy
17 Nov 2014 FDA Approves Bevacizumab in Combination with Chemotherapy for Platinum Resistant, Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
17 Nov 2014 Metatastatic Relapse and Survival After Radical Treatment in Patients with Localised Prostate Cancer and BRCA Mutations Genitourinary cancers - Translational research
14 Nov 2014 Ten Years of Progress in Translational Research in Oncology Translational research
12 Nov 2014 Lung Cancer Screening with Low-Dose CT Could Be Cost Effective Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours
10 Nov 2014 Young Patients With Newly Diagnosed Colorectal Cancer Anticipated to Nearly Double by 2030 Epidemiology/Etiology/Cancer Prevention - Cancer in Special Situations - Gastrointestinal cancers
07 Nov 2014 Olaparib in Patients with BRCA-Related Cancers Cancer in Special Situations - Anticancer agents & Biologic therapy
06 Nov 2014 Facilitating Global Development of Biosimilars Bioethics, legal and economic issues